• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    AdvanSix Appoints Farha Aslam to Board of Directors

    12/14/21 6:45:00 AM ET
    $ASIX
    Major Chemicals
    Industrials
    Get the next $ASIX alert in real time by email

    AdvanSix (NYSE:ASIX) announced today the appointment of Farha Aslam as a new independent member of its Board of Directors. Ms. Aslam is currently Managing Partner of Crescent House Capital, an investment and strategic advisory firm she founded that focuses on the agriculture, energy and food processing industries. Ms. Aslam will serve on the Audit Committee and the Compensation and Leadership Development Committee of the Board of Directors. AdvanSix's Board now consists of 10 members, including nine independent directors.

    "We are very excited to welcome Farha to the AdvanSix Board and leverage her agribusiness experience and financial expertise to progress our corporate strategic priorities," said Michael Marberry, Board Chairman of AdvanSix. "Farha has a unique skill set with decades of experience as a former top Wall Street analyst and current strategic advisor, and we look forward to her leadership and contributions."

    Prior to founding Crescent House Capital in 2019, Ms. Aslam covered the agribusiness sector for nearly two decades as an analyst for Merrill Lynch & Co. and Stephens Inc. At Stephens Inc., she led the firm's Food and Agribusiness equity research team as Managing Director, built a top-tier research franchise that spanned the grain, ethanol, protein, and packaged food sectors, and successfully positioned several lead managed equity offerings and debt financings. Previously, Ms. Aslam was a vice president at Merrill Lynch and a risk management advisor at UBS. Ms. Aslam received her B.A. in Economics from the University of California and holds a Master of Business Administration degree from Columbia University. She also currently serves as a director at Green Plains Inc., Pilgrim's Pride Corporation, and Calavo Growers, Inc.

    "Farha is a valuable addition to our Board, and we look forward to her perspective and insights as we continue to drive the company forward. Her understanding of the investment community and experience serving on the boards of other global leaders in the agribusiness space will provide immense benefits as we support long-term shareholder value," said Erin Kane, president and CEO of AdvanSix.

    About AdvanSix

    AdvanSix plays a critical role in global supply chains, innovating and delivering essential products for our customers in a wide variety of end markets and applications that touch people's lives, such as building and construction, fertilizers, plastics, solvents, packaging, paints, coatings, adhesives and electronics. Our reliable and sustainable supply of quality products emerges from the vertically integrated value chain of our three U.S.-based manufacturing facilities. AdvanSix strives to deliver best-in-class customer experiences and differentiated products in the industries of nylon solutions, chemical intermediates, and plant nutrients, guided by our core values of Safety, Integrity, Accountability and Respect. More information on AdvanSix can be found at http://www.advansix.com.

    Forward-Looking Statements

    This release contains certain statements that may be deemed "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact, that address activities, events or developments that our management intends, expects, projects, believes or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements may be identified by words such as "expect," "anticipate," "estimate," "outlook," "project," "strategy," "intend," "plan," "target," "goal," "may," "will," "should" and "believe" and other variations or similar terminology and expressions. Although we believe forward-looking statements are based upon reasonable assumptions, such statements involve known and unknown risks, uncertainties and other factors, many of which are beyond our control and difficult to predict, which may cause the actual results or performance of the Company to be materially different from any future results or performance expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to: general economic and financial conditions in the U.S. and globally, including the impact of the coronavirus (COVID-19) pandemic and any resurgences; the scope, shape and pace of recovery of the pandemic; the timing of the distribution and efficacy of vaccines or treatments for COVID-19 that are currently available or may be available in the future and related vaccination rates; the severity and transmissibility of newly identified strains of COVID-19; governmental, business and individuals' actions in response to the pandemic, including our business continuity and cash optimization plans that have been, and may in the future be, implemented; the impact of social and economic restrictions and other containment measures taken to combat virus transmission; the effect on our customers' demand for our products and our suppliers' ability to manufacture and deliver our raw materials, including implications of reduced refinery utilization in the U.S.; our ability to sell and provide our goods and services, including as a result of travel and other COVID-19-related restrictions; the ability of our customers to pay for our products; and any closures of our and our customers' offices and facilities; risks associated with increased phishing, compromised business emails and other cybersecurity attacks and disruptions to our technology infrastructure; risks associated with employees working remotely or operating with a reduced workforce; risks associated with our indebtedness including compliance with financial and restrictive covenants, and our ability to access capital on reasonable terms, at a reasonable cost or at all due to economic conditions resulting from COVID-19 or otherwise; the impact of scheduled turnarounds and significant unplanned downtime and interruptions of production or logistics operations as a result of mechanical issues or other unanticipated events such as fires, severe weather conditions, natural disasters and pandemics; price fluctuations, cost increases and supply of raw materials; our operations and growth projects requiring substantial capital; growth rates and cyclicality of the industries we serve including global changes in supply and demand; failure to develop and commercialize new products or technologies; loss of significant customer relationships; adverse trade and tax policies; extensive environmental, health and safety laws that apply to our operations; hazards associated with chemical manufacturing, storage and transportation; litigation associated with chemical manufacturing and our business operations generally; inability to acquire and integrate businesses, assets, products or technologies; protection of our intellectual property and proprietary information; prolonged work stoppages as a result of labor difficulties or otherwise; cybersecurity, data privacy incidents and disruptions to our technology infrastructure; failure to maintain effective internal controls; our ability to declare and pay quarterly cash dividends and the amounts and timing of any future dividends; our ability to repurchase our common stock and the amount and timing of any future repurchases; disruptions in supply chain, transportation and logistics; potential for uncertainty regarding qualification for tax treatment of our spin-off; fluctuations in our stock price; and changes in laws or regulations applicable to our business. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. Such forward-looking statements are not guarantees of future performance, and actual results, developments and business decisions may differ from those envisaged by such forward-looking statements. We identify the principal risks and uncertainties that affect our performance in our filings with the Securities and Exchange Commission (SEC), including the risk factors in Part 1, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2020, as updated in subsequent reports filed with the SEC.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20211213006028/en/

    Get the next $ASIX alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $ASIX

    DatePrice TargetRatingAnalyst
    5/19/2025$32.00Neutral → Overweight
    Piper Sandler
    4/7/2025$26.00Overweight → Neutral
    Piper Sandler
    11/12/2021$58.00Overweight
    Piper Sandler
    More analyst ratings

    $ASIX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Newman Donald P bought $149,089 worth of shares (5,030 units at $29.64) (SEC Form 4)

      4 - AdvanSix Inc. (0001673985) (Issuer)

      11/19/24 4:20:20 PM ET
      $ASIX
      Major Chemicals
      Industrials

    $ASIX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SVP, General Counsel Kintiroglou Achilles B. sold $14,189 worth of shares (571 units at $24.85), decreasing direct ownership by 2% to 31,984 units (SEC Form 4)

      4 - AdvanSix Inc. (0001673985) (Issuer)

      7/2/25 4:30:47 PM ET
      $ASIX
      Major Chemicals
      Industrials
    • Director Williams Patrick was granted 552 shares, increasing direct ownership by 2% to 34,193 units (SEC Form 4)

      4 - AdvanSix Inc. (0001673985) (Issuer)

      7/1/25 4:42:44 PM ET
      $ASIX
      Major Chemicals
      Industrials
    • Director Newman Donald P was granted 977 shares, increasing direct ownership by 9% to 12,026 units (SEC Form 4)

      4 - AdvanSix Inc. (0001673985) (Issuer)

      7/1/25 4:38:50 PM ET
      $ASIX
      Major Chemicals
      Industrials

    $ASIX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • AdvanSix Announces First Quarter 2025 Financial Results

      1Q25 Sales of $378 million, up 12% versus prior year 1Q25 Earnings Per Share of $0.86; Adjusted Earnings Per Share of $0.93 1Q25 Cash Flow from Operations of $11 million, up $48 million versus prior year 1Q25 results include previously announced $26 million final insurance settlement proceeds related to 2019 PES supplier shutdown AdvanSix (NYSE:ASIX), a diversified chemistry company, today announced its financial results for the first quarter ending March 31, 2025. Overall, year-over-year results reflect improved operational performance, continued strength in Plant Nutrients, and the previously announced insurance settlement proceeds. First Quarter 2025 Summary Sales up approximately

      5/2/25 6:30:00 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix to Release First Quarter Financial Results and Hold Investor Conference Call on May 2

      AdvanSix (NYSE:ASIX), a diversified chemistry company, will issue its first quarter 2025 financial results before the opening of the New York Stock Exchange on Friday, May 2. The company will also hold a conference call with investors at 9:30 a.m. ET that day. Conference Call Details To participate on the conference call, dial (844) 855-9494 (domestic) or (412) 858-4602 (international) approximately 10 minutes before the 9:30 a.m. ET start and tell the operator that you are dialing in for AdvanSix's first quarter 2025 earnings call. A replay of the conference call will be available from 12 noon ET on May 2 until 12 noon ET on May 9. You can listen to the replay by dialing (877) 344-7529 (

      4/8/25 6:45:00 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix Announces Fourth Quarter and Full Year 2024 Financial Results

      4Q24 Sales of $329 million, down 14% versus prior year 4Q24 Earnings Per Share of $0.01; Adjusted Earnings Per Share of $0.09 4Q24 Cash Flow from Operations of $64 million, up $4 million versus prior year Progressing 45Q carbon capture tax credits with initial $9.7 million claimed in 4Q24 Final insurance settlement proceeds related to 2019 PES supplier shutdown AdvanSix (NYSE:ASIX), a diversified chemistry company, today announced its financial results for the fourth quarter and full year ending December 31, 2024. Overall, in 2024, the Company achieved commercial success and advanced targeted growth initiatives, while navigating operational challenges in the year. Full Year 2024 Summa

      2/21/25 6:30:00 AM ET
      $ASIX
      Major Chemicals
      Industrials

    $ASIX
    SEC Filings

    See more
    • SEC Form 144 filed by AdvanSix Inc.

      144 - AdvanSix Inc. (0001673985) (Subject)

      7/2/25 4:49:08 PM ET
      $ASIX
      Major Chemicals
      Industrials
    • SEC Form S-8 filed by AdvanSix Inc.

      S-8 - AdvanSix Inc. (0001673985) (Filer)

      6/20/25 4:20:25 PM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - AdvanSix Inc. (0001673985) (Filer)

      6/20/25 4:07:25 PM ET
      $ASIX
      Major Chemicals
      Industrials

    $ASIX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • AdvanSix upgraded by Piper Sandler with a new price target

      Piper Sandler upgraded AdvanSix from Neutral to Overweight and set a new price target of $32.00

      5/19/25 8:45:52 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix downgraded by Piper Sandler with a new price target

      Piper Sandler downgraded AdvanSix from Overweight to Neutral and set a new price target of $26.00

      4/7/25 8:48:39 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • Piper Sandler initiated coverage on AdvanSix with a new price target

      Piper Sandler initiated coverage of AdvanSix with a rating of Overweight and set a new price target of $58.00

      11/12/21 4:57:29 AM ET
      $ASIX
      Major Chemicals
      Industrials

    $ASIX
    Leadership Updates

    Live Leadership Updates

    See more
    • AdvanSix Appoints Sidd Manjeshwar as Senior Vice President and Chief Financial Officer

      AdvanSix (NYSE:ASIX), a diversified chemistry company, announced today the appointment of Sidd Manjeshwar as Senior Vice President and Chief Financial Officer, effective October 1st. In this role, Mr. Manjeshwar will have global responsibility for controllership, treasury, investor relations, procurement, internal audit, commercial finance, tax and financial planning and analysis for the enterprise. Mr. Manjeshwar will report directly to Erin Kane, President and CEO of AdvanSix, and be a member of the Company's executive leadership team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240911629335/en/Sidd Manjeshwar, incoming SVP

      9/12/24 6:30:00 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix Appoints Donald P. Newman to Board of Directors

      AdvanSix (NYSE:ASIX), a diversified chemistry company, announced today the appointment of Donald P. Newman as a new independent member of its Board of Directors. Mr. Newman is currently Executive Vice President, Finance and Chief Financial Officer of ATI Inc., a global producer of high-performance materials and solutions for the global aerospace and defense markets and critical applications in electronics, medical and specialty energy. Mr. Newman will serve on the Audit Committee and the Health, Safety and Environmental Committee of the Board of Directors. AdvanSix's Board now consists of nine members, including eight independent directors. "Don is well recognized for his financial expert

      8/19/24 4:30:00 PM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix Appoints Farha Aslam to Board of Directors

      AdvanSix (NYSE:ASIX) announced today the appointment of Farha Aslam as a new independent member of its Board of Directors. Ms. Aslam is currently Managing Partner of Crescent House Capital, an investment and strategic advisory firm she founded that focuses on the agriculture, energy and food processing industries. Ms. Aslam will serve on the Audit Committee and the Compensation and Leadership Development Committee of the Board of Directors. AdvanSix's Board now consists of 10 members, including nine independent directors. "We are very excited to welcome Farha to the AdvanSix Board and leverage her agribusiness experience and financial expertise to progress our corporate strategic prioritie

      12/14/21 6:45:00 AM ET
      $ASIX
      Major Chemicals
      Industrials

    $ASIX
    Financials

    Live finance-specific insights

    See more
    • AdvanSix Announces First Quarter 2025 Financial Results

      1Q25 Sales of $378 million, up 12% versus prior year 1Q25 Earnings Per Share of $0.86; Adjusted Earnings Per Share of $0.93 1Q25 Cash Flow from Operations of $11 million, up $48 million versus prior year 1Q25 results include previously announced $26 million final insurance settlement proceeds related to 2019 PES supplier shutdown AdvanSix (NYSE:ASIX), a diversified chemistry company, today announced its financial results for the first quarter ending March 31, 2025. Overall, year-over-year results reflect improved operational performance, continued strength in Plant Nutrients, and the previously announced insurance settlement proceeds. First Quarter 2025 Summary Sales up approximately

      5/2/25 6:30:00 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix to Release First Quarter Financial Results and Hold Investor Conference Call on May 2

      AdvanSix (NYSE:ASIX), a diversified chemistry company, will issue its first quarter 2025 financial results before the opening of the New York Stock Exchange on Friday, May 2. The company will also hold a conference call with investors at 9:30 a.m. ET that day. Conference Call Details To participate on the conference call, dial (844) 855-9494 (domestic) or (412) 858-4602 (international) approximately 10 minutes before the 9:30 a.m. ET start and tell the operator that you are dialing in for AdvanSix's first quarter 2025 earnings call. A replay of the conference call will be available from 12 noon ET on May 2 until 12 noon ET on May 9. You can listen to the replay by dialing (877) 344-7529 (

      4/8/25 6:45:00 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix Announces Fourth Quarter and Full Year 2024 Financial Results

      4Q24 Sales of $329 million, down 14% versus prior year 4Q24 Earnings Per Share of $0.01; Adjusted Earnings Per Share of $0.09 4Q24 Cash Flow from Operations of $64 million, up $4 million versus prior year Progressing 45Q carbon capture tax credits with initial $9.7 million claimed in 4Q24 Final insurance settlement proceeds related to 2019 PES supplier shutdown AdvanSix (NYSE:ASIX), a diversified chemistry company, today announced its financial results for the fourth quarter and full year ending December 31, 2024. Overall, in 2024, the Company achieved commercial success and advanced targeted growth initiatives, while navigating operational challenges in the year. Full Year 2024 Summa

      2/21/25 6:30:00 AM ET
      $ASIX
      Major Chemicals
      Industrials

    $ASIX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by AdvanSix Inc. (Amendment)

      SC 13G/A - AdvanSix Inc. (0001673985) (Subject)

      2/13/24 4:55:58 PM ET
      $ASIX
      Major Chemicals
      Industrials
    • SEC Form SC 13G/A filed by AdvanSix Inc. (Amendment)

      SC 13G/A - AdvanSix Inc. (0001673985) (Subject)

      2/9/24 9:58:57 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • SEC Form SC 13G filed by AdvanSix Inc.

      SC 13G - AdvanSix Inc. (0001673985) (Subject)

      2/7/24 8:39:58 AM ET
      $ASIX
      Major Chemicals
      Industrials